| 中文名称 | 英文名称 | CAS号 | 化学式 |
|---|---|---|---|
| NPC-15437二盐酸盐 | NPC 15437 | 136449-85-9 | C25H50N4O2 |
| NOTA-BIS(叔丁基酯) | 2-(4,7-bis(2-(tert-butoxy)-2-oxoethyl)-1,4,7-triazonan-1-yl)acetic acid | 1161415-28-6 | C20H37N3O6 |
| NORPROPOXYPHENEMALEATE标准品 | D-Norpropoxyphene maleate salt | 38910-73-5 | C25H31NO6 |
| NO-泼尼松龙 | prednisolone 21-[(4’-nitro-oxymethyl)benzoate] | 327610-87-7 | C29H33NO9 |
| NO-冯-PDETMPPI | NO-Feng-PDEtMPPi | 1502814-74-5 | C37H56N4O4 |
| NN-二甲基哌啶-4-胺盐酸盐 | N,N-dimethylpiperidin-4-amine dihydrochloride | 172281-90-2 | C7H16N2*2ClH |
| NN-二甲基-L-丙氨酸 | N,N-dimethyl-L-alanine | 2812-31-9 | C5H11NO2 |
| NN-二乙基-2-哌嗪-1-基烟碱 | N,N-Diethyl-2-Piperazin-1-Yl-Nicotinamide | 902836-85-5 | C14H22N4O |
| NN-[(1,1-二甲基乙氧基)羰基]-4-[(甲基磺酰基)氨基]-L-苯基丙氨酸 | N-t-butoxycarbonyl-DL-4-(methylsulfonylamino)phenylalanine | 204856-74-6 | C15H22N2O6S |
| NLG-919中间体4 | 1-cyclohexyl-2-(5H-imidazo[5,1-a]isoindol-5-yl)ethanone | 1402838-89-4 | C18H20N2O |
| NLG-919中间体 | 2-(1-trityl-1H-imidazol-4-yl)benzaldehyde | 1402838-08-7 | C29H22N2O |
| NKH477(达福尔考辛) | NKH 477 | 138605-00-2 | C27H43NO8*ClH |
| NK110树脂 | N-Ethyl-N'-propyl-piperazin | 90796-44-4 | C9H20N2 |
| NK-611盐酸盐 | VP 19 Hydrochloride | 105760-98-3 | C31H38ClNO12 |
| NK-1拮抗剂1 | (3S,6S)-6-({(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy}methyl)-3-(5-oxo-1,5dihydro-4H-1,2,4-triazol-4-yl)-6-phenylpiperidine-3-carbonitrile | 873947-10-5 | C25H23F6N5O2 |
| NILUTAMIDEEP杂质A | 5-imino-4,4-dimethyl-1-(4-nitro-3-trifluoromethyl-phenyl)-imidazolidin-2-one | 63612-49-7 | C12H11F3N4O3 |
| NI(a)-类似的蛋白质 | hydron;N-methyl-3-(2-phenylphenoxy)propan-1-amine;chloride | —— | C16H20ClNO |
| NHS-双吖丙啶 | 2,5-dioxopyrrolidin-1-yl 3-(3-methyl-3H-diazirin-3-yl)propanoate | 1239017-80-1 | C9H11N3O4 |
| NHPI-四聚乙二醇-C2-琥珀酰亚胺酯 | 2,5-dioxopyrrolidin-1-yl 1-((1,3-dioxoisoindolin-2-yl)oxy)-3,6,9,12-tetraoxapentadecan-15-oate | 1415328-95-8 | C23H28N2O11 |
| NHC-PD(II)-IM催化剂 | methyl (1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,19E,21E,23E,25E,27E,29E,31E,33R,35S,36R,37S)-33-[(2R,3S,4S,5S,6R)-3,5-dihydroxy-6-methyl-4-[methyl-[[(2R,3S,4R,5R)-2,3,4,5-tetrahydroxyoxan-2-yl]methyl]amino]oxan-2-yl]oxy-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaene-36-carboxylate | 1314876-23-7 | C55H87NO22 |
| NH2CH2CONH-PY2-四嗪盐酸盐 | 2-amino-N-(6-(6-(pyridin-2-yl)-1,2,4,5-tetrazin-3-yl)pyridin-3-yl)acetamide hydrochloride | 1360467-41-9 | C14H12N8O*ClH |
| NH-双(四聚乙二醇-羟基) | NH-bis(PEG4-OH) | 63721-06-2 | C20H43NO10 |
| NH-双(二聚乙二醇-羟基) | 3,6,12,15-tetraoxa-9-azaheptadecane-1,17-diol | 25743-12-8 | C12H27NO6 |
| NH-双(二聚乙二醇-炔基) | NH-bis(PEG2-propargyl) | 2100306-83-8 | C14H23NO4 |
| NH-双(二聚乙二醇-叔丁酯) | di-tert-butyl 4,7,13,16-tetraoxa-10-azanonadecanedioate | 1964503-36-3 | C22H43NO8 |
| NH-双(三聚乙二醇-叠氮) | bis(2-(2-(2-(2-azidoethoxy)ethoxy)ethoxy)ethyl)amine | 1258939-39-7 | C16H33N7O6 |
| NH-BIS(三聚乙二醇-叔丁氧羰基) | NH-bis(PEG3-Boc) | 2055024-51-4 | C26H53N3O10 |
| NH-BIS(一聚乙二醇-羟基) | 3,9-dioxa-6-azaundecane-1,11-diol | 54384-47-3 | C8H19NO4 |
| NG,N'G-二甲基-L-精氨酸二(对羟基偶氮苯-p'-磺酸盐) | 4-Azaniumyl-4-carboxy-N-[(dimethylamino)(iminio)methyl]butan-1-aminide | 102783-24-4 | C8H19N4O2+ |
| NG-单甲基-L-精氨酸醋酸盐 | NG-monomethyl-L-arginine monoacetate | 53308-83-1 | C2H4O2*C7H16N4O2 |
| NF-κB活化抑制剂VI | 2-phenylimino-4-oxo-4,5,6,7-tetrahydro-6,6-dimethyl-1,3-benzoxathiole | 113760-29-5 | C15H15NO2S |
| NEUROTENSIN(8-13)肽 | Arginyl-arginyl-prolyl-tyrosyl-isoleucyl-leucine | 60482-95-3 | C38H64N12O8 |
| NDI-双C8C12-双噻吩-双溴 | N,N′-bis(2-octyldodecyl)-2,6-bis(5-bromothiophenyl-5-yl)-1,4,5,8-naphthalene diimide | 1178586-27-0 | C62H88Br2N2O4S2 |
| ND-646中间体 | (R)-2-(2-methoxyphenyl)-2-((tetrahydro-2H-pyran-4-yl)oxy)ethan-1-ol | 1434652-66-0 | C14H20O4 |
| NBI35965盐酸盐 | NBI-35965 Mesylate | 603151-83-3 | C22H26Cl2N4O3S |
| NBD胆固醇 | (3S,8S,9S,10R,13S,14S,17R)-10,13-dimethyl-17-[(2S)-1-[(4-nitro-2,1,3-benzoxadiazol-7-yl)amino]propan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol | 78949-95-8 | C28H38N4O4 |
| NBD-双十六胺 | 4-Benzofurazanamine, N,N-dihexadecyl-7-nitro- | 117056-66-3 | C38H68N4O3 |
| NBD-CO-HZ[=4-(N-肼羰甲基-N-甲氨基)-7-硝基-2,1,3-苯并恶二唑] | 4-(N-hydrazinocarbonylmethyl-N-methylamino)-7-nitro-2,1,3-benzoxadiazole | 221263-97-4 | C9H10N6O4 |
| NBD-556; N-(4-氯苯基)-N'-(2,2,6,6-四甲基哌啶-4-基)草酰胺 | NBD-556 | 333353-44-9 | C17H24ClN3O2 |
| NBC抑制剂(S0859) | 2-Chloro-N-((2'-(N-cyanosulfamoyl)-[1,1'-biphenyl]-4-yl)methyl)-N-(4-methylbenzyl)benzamide | 1019331-10-2 | C29H24ClN3O3S |
| NB-598马来酸盐 | (E)-N-(6,6-dimethyl-2-hepten-4-ynyl)-N-ethyl-3-[4-(thien-3-yl)-thien-2-ylmethyloxy]benzylamine maleate | 155294-62-5 | C4H4O4*C27H31NOS2 |
| NA无结构图 | 7-amino-5-(4-methoxy-benzyl)-5H,7H-dibenzo[b,d]azepin-6-one hydrochloride | 1083065-04-6 | C22H20N2O2*ClH |
| NA无结构图 | 5-(4-methoxybenzyl)-5H-dibenzo[b,d]azepin-6(7H)-one | 847926-44-7 | C22H19NO2 |
| NAlpha-芴甲氧羰基-O-三苯代甲基-L-增丝氨酸 | N<sup>α</sup>-Fmoc-O-Trt-Hse | 111061-55-3 | C38H33NO5 |
| NAlpha-芴甲氧羰基-Nγ-羰-L-2,4-氨基丁酸 | (S)-4-tert-butoxycarbonylamino-2-(9H-fluoren-9-ylmethoxycarbonylamino)butyric acid | 125238-99-5 | C24H28N2O6 |
| NAlpha-甘氨酰-DL-天冬酰胺 | glycyl-DL-asparagine | 32729-21-8 | C6H11N3O4 |
| NAlpha-叔丁氧羰基-Nim-苄基-L-组氨酸 | Boc-His(Bzl)-OH | 20898-44-6 | C18H23N3O4 |
| NAlpha-FMOC-Nω-PMC-D-精氨酸 | Fmoc-D-Arg(Pmc)-OH | 157774-30-6 | C35H42N4O7S |
| NAlpha-CBZ-L-精氨酸盐酸盐 | N<sup>α</sup>-Z-L-arginine hydrobromide | 73496-41-0 | BrH*C14H20N4O4 |
| NAlpha-BOC-Nε-FMOC-L-赖氨酸 | Boc-Lys(Fmoc)-OH | 84624-27-1 | C26H32N2O6 |